BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38184141)

  • 21. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
    Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
    Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application.
    Li M; Li L; Zheng J; Li Z; Li S; Wang K; Chen X
    Mol Cancer; 2023 Feb; 22(1):37. PubMed ID: 36810071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid biopsy in germ cell tumors: biology and clinical management.
    Chovanec M; Kalavska K; Mego M; Cheng L
    Expert Rev Mol Diagn; 2020 Feb; 20(2):187-194. PubMed ID: 31652083
    [No Abstract]   [Full Text] [Related]  

  • 24. The Implication of Liquid Biopsy in the Non-small Cell Lung Cancer: Potential and Expectation.
    Ren J; Liu R
    Methods Mol Biol; 2023; 2695():145-163. PubMed ID: 37450117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Ye Q; Ling S; Zheng S; Xu X
    Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis.
    Karimi F; Azadbakht O; Veisi A; Sabaghan M; Owjfard M; Kharazinejad E; Dinarvand N
    Med Oncol; 2023 Aug; 40(9):265. PubMed ID: 37561363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
    Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
    Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
    Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid Biopsy in Bladder Cancer.
    Cui Y; Cao M
    Methods Mol Biol; 2023; 2695():111-120. PubMed ID: 37450114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
    Junqueira-Neto S; Batista IA; Costa JL; Melo SA
    Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical application and detection techniques of liquid biopsy in gastric cancer.
    Ma S; Zhou M; Xu Y; Gu X; Zou M; Abudushalamu G; Yao Y; Fan X; Wu G
    Mol Cancer; 2023 Jan; 22(1):7. PubMed ID: 36627698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid Biopsy: General Concepts.
    Poulet G; Massias J; Taly V
    Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An emerging technique for the dual‑targeting chemo‑radio‑ablation of generic micro‑cancers in conjunction with cancer liquid biopsy.
    Ni Y
    Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36579662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
    Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
    Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders.
    Mithraprabhu S; Chen M; Savvidou I; Reale A; Spencer A
    Leukemia; 2021 Oct; 35(10):2771-2783. PubMed ID: 34262132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid Biopsy: A Game Changer for Type 2 Diabetes.
    Gradisteanu Pircalabioru G; Musat M; Elian V; Iliescu C
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
    Ray SK; Mukherjee S
    Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 39. Liquid Biopsy: Current Status and Future Perspectives.
    Mader S; Pantel K
    Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
    Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
    Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.